3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Weight Loss
1
SCLC, Limited Stage
1
Pediatric Obesity
1
Pain, Postoperative
1
Obesity
1
Neoplasms
1
Multiple Myeloma
1
Liver Neoplasms
1
Laryngeal Neoplasms
1
Gynecologic Oncology Patient
1
Emotional Regulation
1
Cognitive Dysfunction
1
Anxiety Disorders
1
Interventions
rozanolixizumab
8
zilucoplan
7
ravulizumab
6
fludarabine
5
efgartigimod alfa
5
Cyclophosphamide
5
telitacicept
3
Prednisone
3
inebilizumab
2
Rituximab
2
Pyridostigmine Bromide
2
tofacitinib
1
thymoglobulin
1
talquetamab
1
remibrutinib
1
prednylidene
1
iptacopan
1
eculizumab
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Walk Test
1
Therapeutics
1
Tacrolimus
1
Steroids
1
Robotic Surgical Procedures
1
Psychodrama
1
Prednisolone
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Oxaloacetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myasthenia Gravis
×
Population Groups
×
1 year
×
Clear all
No trials found.